← FDA Drug Approvals (Drugs@FDA)

AMPHOTERICIN B

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AVET LIFESCIENCES · Approved 2025-06-02

Drug application

FDA Application #
ANDA215354
Application type
Abbreviated New Drug Application (Generic)
Brand name
AMPHOTERICIN B
Generic name
AMPHOTERICIN B
Active ingredients
AMPHOTERICIN B
Dosage form
INJECTABLE, LIPOSOMAL
Route
INJECTION
Marketing status
Prescription
Sponsor
AVET LIFESCIENCES
Manufacturer
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
First approval
2025-06-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown